Brain Tumors 2016: From Biology to Therapy
| DAY 1 Monday, 27 June | ||
| 08:00 - 09:00 | Registration and welcome coffee | |
| 09:00 - 09:10 | Opening remarks | |
| 09:10 - 12:50 | Origins of brain tumors and glioblastoma heterogeneity (chairs: Dolores Hambardzumyan, Bozena Kaminska) | |
| 09:10 - 10:00 | Keynote lecture: Colin Watts - Surgical strategies to interrogate the genomics of glioblastoma University of Cambridge, UK |
|
| 10:00 - 10:40 | Dominik Sturm - Molecular characterization of CNS primitive neuroektodermal tumors University Hospital Heidelberg and German Cancer Research Center, Germany |
|
| 10:40 - 11:10 | COFFEE BREAK | |
| 11:10 - 11:50 | Lene Uhrbom - A cell of origin - based strategy to decipher glioblastoma biology University of Uppsala, Sweden |
|
| 11:50 - 12:30 | Simone Niclou - Resolving genetic and phenotypic heterogeneity in glioblastoma Luxemburg Institute of Health, Luxemburg |
|
| 12:30 - 13:10 | Benjamin Deneen - Identification of diverse astrocytic populations and their emergence during glioma induced seizures Baylor College of Medicine, Houston, USA |
|
| 13:10 - 14:00 | Lunch break and sponsored lecture Adam Olejnik - SeqCap EZ MedExome Target Enrichment Kit. Coverage with Confidance Roche Diagnostics Polska | |
| 14:00 - 17:20 | Brain tumor therapy (chairs: Zvi Cohen, Pawel Nauman) | |
| 14:00 - 14:40 | Zvi Cohen - Harnessing nanomedicine as a new approach for GBM treatment Sheba Medical Center, Tel Ashomer, Israel |
|
| 14:40 - 15:20 | Geoffrey Pilkington - A role for new therapeutic targets and re-purposed/re-formulated drugs in glioma therapy University of Portsmouth, UK |
|
| 15:20 - 16:00 | Joan Seoane - Glioblastoma microenvironment Vall d’Hebron Institute of Oncology, Spain |
|
| 16:00 - 16:30 | COFFEE BREAK | |
| 16:30 - 17:10 | Oral presentations selected from submitted abstracts • Susan Brandenburg - In human GBM, the pro-angiogenic phenotype of microglia/macrophages depends on the infiltration rate of granulocytes Charité - Universitätsmedizin Berlin, Germany • Roland E. Kälin - Apelin signaling controls glioblastoma neo-vascularization and growth University Clinics, LMU Munich, Germany • Dominika Pszczolkowska - Tumor-derived osteopontin via its RGD motif is responsible for the protumorigenic reprogramming of glioma- infiltrating microglia/macrophages and glioma growth Nencki Institute of Experimental Biology, Poland |
|
| 17:10 - 17:50 | Rolf Bjerkvig - Identifying new drugs for primary and secondary brain tumours using cMap University of Bergen, Norway |
|
| 18:30 - 21:00 | Welcome reception at Staszic Palace (Palac Staszica, Nowy Świat 72, Warsaw) | |
| DAY 2 Tuesday, 28 June | ||
| 09:00 - 12:20 | Signaling in brain tumors (chairs: Lene Uhrbom, Aleksandra Ellert-Miklaszewska) | |
| 09:00 - 09:50 | Keynote lecture: Daniel J. Brat - A contemporary molecular view of diffuse gliomas with implications for diagnosis Winship Cancer Institute of Emory University, Atlanta, USA |
|
| 09:50 - 10:30 | Ksenya Shchors - Combinatorial therapy design in glioblastoma models Swiss Federal Institute of Technology, Switzerland |
|
| 10:30 - 11:00 | COFFEE BREAK | |
| 11:00 - 11:40 | Etty (Tika) Benveniste - Role of CK2 in GBM and autoimmunity University of Alabama, Birmingham, USA |
|
| 11:40 - 12:20 | Bozena Kaminska - Glioma-derived osteopontin/SPP1 supports glioma stem-like cells and blocks anti-tumor responses Nencki Institute, Warsaw, Poland |
|
| 12:20 - 13:10 | LUNCH | |
| 13:10 - 17:00 | Glioma immunology and immunotherapy (chairs: Tika Benveniste, Katarzyna Kotulska) | |
| 13:10 - 13:50 | Duane Mitchell - Cellular immunotherapy targeting malignant gliomas University of Florida, USA |
|
| 13:50 - 14:30 | Dolores Hambardzumyan - The role of pro-inflammatory chemokine network in gliomagenesis Emory University School of Medicine, Atlanta, USA |
|
| 14:30 - 15:10 | Christel Herold-Mende - Immunological changes during tumor progression from primary to recurrent glioblastoma University Hospital Heidelberg, Germany |
|
| 15:10 - 15:40 | COFFEE BREK | |
| 15:40 - 16:20 | Michael Platten - Targeting IDH1R132H for glioma immunotherapy University Hospital Heidelberg and German Cancer Research Center, Germany |
|
| 16:20 - 17:00 | Gaetano Finocchiaro - Glioblastoma immunotherapy IRCCS Foundation "C. Besta" Neurological Institute, Milan, Italy |
|
| 17:00 - 19:00 | Poster session (wine and cheese by the posters) | |
| 20:00 - 23:00 | Gala dinner (by invitation) | |
| DAY 3 Wednesday, 29 June | ||
| 09:00 - 14:10 | Glioma signaling and biology (chairs: Frank AE Kruyt, Cristina Limatola) | |
| 09:00 - 09:40 | Keynote lecture: Katarzyna Kotulska - mTOR inhibitors in tuberous sclerosis: from brain tumor treatment to the control of systemic disease The Children’s Memorial Health Institute, Poland |
|
| 09:40 - 10:20 | Monika Hegi - Epigenetic Deregulation in Glioma, Biomarkers and New Opportunities University Hospital Lausanne, Switzerland |
|
| 10:20 - 11:00 | Steven Rosenfeld - Molecular motors are drivers of proliferation and invasion in glioblastoma Cleveland Clinic, USA |
|
| 11:00 - 11:30 | COFFEE BREAK | |
| 11:30 - 12:10 | Frank AE Kruyt - Differentiation and invasion in glioblastoma University of Groningen, Netherlands |
|
| 12:10 -12:50 | Cristina Limatola - Environmental and pharmacological tools to reprogram microglia/macrophages infiltrating brain tumor Sapienza University, Rome, Italy |
|
| 12:50 - 13:30 | Jacek Jaworski - Tuberous Sclerosis Complex neuropathology requires glutamate-cysteine ligase International Institute of Molecular and Cellular Biology, Warsaw, Poland |
|
| 13:30 - 14:10 | Farewell lunch | |
| 14:15 - | Guided tour: Warsaw sightseeing | |